RiverPark Advisors LLC Lowers Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

RiverPark Advisors LLC lowered its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 15.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,480 shares of the medical equipment provider’s stock after selling 818 shares during the period. Intuitive Surgical accounts for 1.8% of RiverPark Advisors LLC’s investment portfolio, making the stock its 18th biggest position. RiverPark Advisors LLC’s holdings in Intuitive Surgical were worth $2,201,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. Hazlett Burt & Watson Inc. grew its position in shares of Intuitive Surgical by 5.8% in the third quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock valued at $177,000 after purchasing an additional 20 shares during the period. Mitchell Mcleod Pugh & Williams Inc. grew its position in shares of Intuitive Surgical by 4.1% in the third quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock valued at $247,000 after purchasing an additional 20 shares during the period. Ullmann Wealth Partners Group LLC grew its position in Intuitive Surgical by 1.6% during the third quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock valued at $653,000 after acquiring an additional 21 shares during the period. One Wealth Management Investment & Advisory Services LLC grew its position in Intuitive Surgical by 3.4% during the second quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock valued at $310,000 after acquiring an additional 23 shares during the period. Finally, Falcon Wealth Planning grew its position in Intuitive Surgical by 0.4% during the third quarter. Falcon Wealth Planning now owns 5,693 shares of the medical equipment provider’s stock valued at $2,797,000 after acquiring an additional 23 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction that occurred on Thursday, August 29th. The stock was sold at an average price of $482.21, for a total transaction of $90,655.48. Following the sale, the executive vice president now owns 5,506 shares in the company, valued at $2,655,048.26. This represents a 3.30 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, SVP Henry L. Charlton sold 40,243 shares of the company’s stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total value of $19,591,902.12. Following the sale, the senior vice president now owns 3,001 shares in the company, valued at $1,461,006.84. The trade was a 93.06 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 91,178 shares of company stock worth $45,897,071 over the last quarter. 0.90% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

ISRG has been the subject of a number of research reports. Evercore ISI reissued a “cautious” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Mizuho boosted their price target on Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Piper Sandler reissued an “overweight” rating and set a $538.00 price target (up previously from $495.00) on shares of Intuitive Surgical in a research report on Friday, October 18th. Leerink Partners boosted their price target on Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. Finally, Royal Bank of Canada boosted their price target on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research report on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $513.74.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $527.61 on Friday. Intuitive Surgical, Inc. has a one year low of $295.02 and a one year high of $544.38. The business’s 50-day simple moving average is $499.29 and its 200 day simple moving average is $457.89. The stock has a market cap of $187.92 billion, a price-to-earnings ratio of 84.82, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The business had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.